Latest filing published 19 Oct 2026 for TELA Bio, Inc., €14k.
No signal scores available.
William J. Plovanic discloses dealings in TELA Bio, Inc. to SEC (Form 4). Over a trading history stretching from 31 October 2025 to 15 October 2026, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 19 October 2026, the filings show a share grant worth €14k in TELA Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations